Pilot test of an online training module on near-infrared spectroscopy monitoring for the randomised clinical trial SafeBoosC-III
Abstract Background SafeBoosC-III is an international randomised clinical trial to evaluate the effect of treatment of extremely preterm infants during the first 3 days of life based on cerebral near-infrared spectroscopy (NIRS) monitoring versus treatment and monitoring as usual. To ensure high qua...
Main Authors: | Mathias Lühr Hansen, Marie Isabel Rasmussen, Snorre Rubin, Adelina Pellicer, Guoqiang Cheng, Xin Xu, Yin Zhaoqing, Vibeke Zoffmann, Gorm Greisen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-04-01
|
Series: | Trials |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13063-020-4206-6 |
Similar Items
-
Cerebral near-infrared spectroscopy monitoring versus treatment as usual for extremely preterm infants: a protocol for the SafeBoosC randomised clinical phase III trial
by: Mathias Lühr Hansen, et al.
Published: (2019-12-01) -
Detailed statistical analysis plan for the SafeBoosC III trial: a multinational randomised clinical trial assessing treatment guided by cerebral oxygenation monitoring versus treatment as usual in extremely preterm infants
by: Mathias Lühr Hansen, et al.
Published: (2019-12-01) -
Central data monitoring in the multicentre randomised SafeBoosC-III trial – a pragmatic approach
by: Markus Harboe Olsen, et al.
Published: (2021-07-01) -
Extremely Preterm Infant Admissions Within the SafeBoosC-III Consortium During the COVID-19 Lockdown
by: Marie Isabel Rasmussen, et al.
Published: (2021-07-01) -
Reality TV's "queen of all :" genre, transgression, and hierarchy in Here Comes Honey Boo Boo
by: Hicks, Shannon Nicole
Published: (2014)